Actively Recruiting
Evaluating Treatment and Quality Improvement for Adults with Acute ST-Elevation Myocardial Infarction in China
Led by China National Center for Cardiovascular Diseases · Updated on 2019-10-09
200000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating clinical performance and quality measures for adults with acute ST-elevation myocardial infarction STEMI in China. This study aims to develop quality improvement strategies and tools to enhance treatment and clinical outcomes for patients with STEMI. It is conducted as an annual survey enrolling all eligible inpatients to assess hospital performance and care variations across regions. The study involves all participating hospitals implementing quality improvement strategies, including summaries of clinical performance, clinical pathways, and professional training programs. Eligible patients are consecutively recruited using consistent methods, and the study tracks reperfusion rates and other performance measures yearly to compare improvements over time. Participants will have their demographic data, clinical features, diagnostic tests, medications, procedures, and in-hospital outcomes collected. Researchers measure various outcomes such as medication use at arrival and discharge, timing of treatments like thrombolysis and primary PCI, mortality rates, readmission rates, and cost during hospitalization. The study continues long term with annual data collection to monitor quality and outcomes up to the year 2035.
CONDITIONS
Brief Title
Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China
Research Team
H
Hongjian Wang
K
Kefei Dou
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
